Abstract
The techniques for bone-marrow transplantation grew out of the studies by Jacobson, et al. [1] and Lorenz et al. [2], first reported in 1950. They showed that lethally irradiated mice could survive if the spleen was adequately shielded or if an infusion of bone-marrow cells was given. Initial efforts in man to utilize the technique of marrow infusion following lethal radiation demonstrated the potential usefulness of this technique but were generally unsuccessful. In the late 1950s two leukemia patients given supralethal radiation demonstrated successful engraftment after marrow infusion from identical twin donors but later succumbed to recurrent disease [3]. With the advances in kidney transplantation in the 1960s, the role of histocompatability matching between donor and recipient was appreciated. Elucidation of the histocompatability leukocyte antigen (HLA) complex facilitated marrow transplantation between HLA-identical siblings. In the early 1970s marrow transplantation was further enhanced with the development of better supportive care for patients following marrow ablation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jacobson LO, Simmons EL, Marks EK, et al.: The role of the spleen in radiation injury and recovery. J Lab Clin Med (35):746–770, 1950.
Lorenz E, Uphoff D, Reid TR, Shelton E: Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst (12):197–201, 1951.
Thomas ED, Lochte HLJr, Lu WC, Ferrebee JW: Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med (257):491–496, 1957.
Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rapport JM, Santos G, Gordon-Smith EC, Storb R: A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (53):504–514, 1979.
Storb R, Doney KC, Thomas ED, Appelbaum F, Buckner CD, Clift RA: Marrow transplantation with or without buffy coat cells for 65 transfused aplastic anemia patients. Blood (59):236–246, 1982.
Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HS, Fefer A, Goodell RW, Sale GE, Sanders J, Singer J, Stewart P, Weiden PL: Marrow transplantation in thirty “untransfused” patients with severe aplastic anemia. Ann Intern Med (92):30–36, 1980.
Thomas ED, Buckner ED, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE, Singer JW, Shulman H, Storb R, Weiden PL: Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med (301):597–599, 1979.
Fefer A, Cheever MA, Greenberg PD, Appelbaum FR, Boyd W, Buckner CD, et al.: Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins. N Engl J Med (306):63–68, 1982.
Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER: Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med (303):565–567, 1980.
Thomas DE: Bone marrow transplantation: Present status and future expectations. In Update I; Harrison’s Principles of Internal Medicine, Issenbach KJ, Adams RA, Braunwald E, Martin JB, Petersdorf RG, Wilson JD (eds), New York, McGraw-Hill, 1981.
Appelbaum FR, Fefer A, Cheever MA, Sanders JE, Singer JW, Adamson JW, Mickelson EM, Hansen JA, Greenberg PD, Thomas ED: Treatment of aplastic anemia by bone marrow transplantation in identical twins. Blood (55):1033–1039, 1980.
Clift RA, Hansen JA, Thomas ED: The role of HLA in marrow transplantation. Transplant Proc (13):- 234–236, 1981.
Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone marrow transplantation. N Engl J Med (292):832–843, 895–902, 1975.
Neiman P, Thomas ED, Buckner CD, Storb R, Fefer A, Glucksberg H, Lerner KG: Marrow transplantation for aplastic anemia and acute leukemia. Ann Rev Med (25):179–198, 1974.
Meyers JD, Thomas ED: Infection complicating bone marrow transplantation. In Clinical Approach to Infection in the Immunocompromised Host, Young LS, Rubin RH (eds), New York, Plenum, 1981.
Buckner CD, Clift RA, Sanders JE, Meyers JD, Counts GW, Farewell VT, Thomas ED: Protective environment for marrow transplant recipients. A prospective study. Ann Int Med (89):893–901, 1978.
Clift RA, Sanders JE, Thomas ED, Williams B, Buckner CD: Granulocyte transfusions for the prevention of infection in patients receiving bone marrow transplants. N Engl J Med (298):1052–1057, 1978.
Sarai R, Burns WH, Laskin DL, Santos GW, Lietman P: Acyclovir prophylaxis of herpes simplex infections: A randomized, double blind, controlled trial in bone marrow transplant recipients. N Engl J Med (305):63–67, 1981.
Hickman RO, Buckner CO, Clift RA, Sanders JE, Stewart P, Thomas ED: A modified right arterial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet (148):871–875, 1979.
Storb R: Bone marrow transplantation for the treatment of hematologic malignancy and of aplastic anemia. Transplant Proc (13):221–226, 1981.
Slavin RE, Santos GW: The graft-versus-host reaction in man after bone marrow transplantation: Pathology, pathogenesis, clinical features and implications. Clin Immunol Immunopathol (1):472–498, 1973.
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED; Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors. Transplantation (18):295–304, 1974.
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED: Chronic graft-versus-host syndrome in man. A long term clinicopathologic study of 20 Seattle patients. Am J Med (69):204–217, 1982.
Atkinson K, Storb R, Prentice RL, Weiden P, Witherspoon RP, Sullivan KM, Noel D, Thomas ED: Analysis of late infections in 89 long term survivors of bone marrow transplantation. Blood (53):720–731, 1979.
Powles RL, Clink HM, Spence D, Morgenstern G, Watson JG, Selby PJ, Woods M, Barrett A, Jameson B, Sloane J, Lawler SD, Kay H, Lawson D, McElwain T, Alexander P: Cyclosporin A to prevent graft-versus- host disease in man after allogeneic bone marrow transplantation. Lancet (8164):327—329, 1980.
Weiden PL, Fluornoy N, Sanders JF, Sullivan KM, Thomas ED: Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. Transplant Proc (12):- 248–251, 1981.
Sullivan KM, Shulman HM, Storb R, Weider PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED: Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood (57):267–276, 1981.
Witherspoon RP, Kopecky K, Storb RF, Fluornoy N, Sullivan KM, Sosa R, Deeg HJ, Ochs HD, Cheevers MA, Fefer A, Thomas ED: Immunological recovery in 48 patients following syngeneic marrow transplantation for hematological malignancy. Transplantation (33):143–149, 1982.
Witherspoon RP, Storb R, Ochs Hd, Flournoy N, Kopecky K, Sullivan KM, Deeg HJ, Sosa R, Noel DR, Atkinson K, Thomas ED: Recovery of antibody, production in human allogeneic marrow graft recipients: Influence of time post transplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood (58):360–368, 1981.
Tsoi MS, Storb R, Dobbs S, Kopecky KJ, Santos E, Weiden PL, Thomas ED: Nonspecific suppressor cells in patients with chronic graft-versus-host disease after marrow grafting. J Immunol (123):1970–1976, 1979.
Tsoi MS, Storb R, Dobb S, Thomas ED: Specific suppressor cells in graft-host tolerance of HLA-identical marrow transplantation. Nature (292):355–357, 1981.
Lockhart PB, Sonis ST: Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy. Oral Surg (48):21–28, 1979.
Dreizen S, Bodey GP, Rodriquez V: Oral complications of cancer chemotherapy. Postgrad Med (58):75–82, 1975.
Silverman S: Radiation effects. In Oral Cancer, Silverman S (ed), New York, American Cancer Society, 1981.
Dreizen S: Stomatotoxic manifestations of cancer chemotherapy. J Prosthet Dent (40):650–655, 1978.
Gershwin ME, Goetzl EJ, Steinberg AD: Cyclophosphamide: Use in practice. Ann Intern Med (80):531–540, 1974.
Chabner BA, Myers CE, Coleman CN, Johns DG: The clinical pharmacology of antineoplastic agents. N Engl J Med (292):1107–1113, 1159–1168, 1975.
Dreizen S, Bodey GP, Brown LR: Opportunistic gram-negative bacillary infections in leukemia—oral manifestations during myelosuppression. Postgrad Med (55):133–139, 1974.
Solberg CO, Meuwissen HJ, Needham RN, Good RA, Matsen JM: Infectious complications in bone marrow transplant patients. Br Med J (l):18–23, 1971.
Dreizen S, McCredie KB, Sicke KA, Zander AR, Peters JL: Oral complications of bone marrow transplantation in adults with acute leukemia. Postgrad Med (66):187–194, 1979.
Morris PG: Cyclosporin A: Overview. Transplantation (32):349–354, 1981.
Schubert MM, Truelove EL, Sullivan KM, Izutsu KT, Flournoy N, Kolbinson DA: Oral signs of chronic graft-versus-host disease. Proc J Dent Res (68):263, 1982.
Sale GE, Shulman HM, Schubert MM, Sullivan KM, Kopecky KJ, Hackman RC, Morton TH, Storb R, Thomas ED: Oral and opthalmic pathology of graft versus host disease in man: Predictive value of the lips biopsy. Hum Pathol (12):1022–1030, 1981.
Gratwohl AA, Moutsopoulos HM, Chused TM, Akizuki M, Wolf RO, Sweet JB, Reisseroth AB: Sjogren-type syndrome after allogeneic bone marrow transplantation. Ann Intern Med 87:703—706, 1977.
Mandel ID, Burmash H: Sialochemistry in Sjogren’s syndrome. Oral Surg, Oral Med, Oral Pathol (41): 182–187, 1976.
Moutsopoulous H, Karsh J, Wolf R, Tarpley T: Lysozyme determination in parotid saliva from patients with Sjogren’s syndrome. Am J Med (69):39–42, 1980.
Izutsu K, Oberg S, Shulman H, Schubert M, Sullivan K, Morton T, Sale G, Truelove E: Depressed salivary IgA; and sodium and flow changes in C-GVHD patients. J Supramol Struct (Suppl A):24, 1980.
Izutsu KT, Schubert MM, Shulman H, Oberg S, Sullivan KM, Rice J, Morton T, Truelove E: Salivary changes in graft-versus-host disease (GVHD) Proc J Dent Res (95-A): 401, 1980.
Izutsu KT, Truelove EL, Schubert MM, Ensign WY, Meadows EE: Does graft-versus-host disease cause hyposalivation in bone marrow transplant recipients? Proc J Dent Res (68):263, 1982.
Truelove EL, Izutsu KT, Schubert MM, Ensign WT, Meadows EE: Salivary lysozyme levels are increased in bone marrow transplant (BMT) recipients. Proc J Dent Res (68):223, 1982.
Izutsu KT, Schubert MM, Truelove EL, Shulman HM, Sale GE, Morton TH, Ensign WY, Mersai T, Thomas DE: The predictive value of elevated sodium concentration: Its relation to labial gland pathology in bone marrow transplant recipients. Hum Pathol (May 1982, in press).
Beschorner WE, Yardley JH, Tutschka PJ, Santos GW: Deficiency of intestinal immunity with graft-versus- host disease in humans. J Infect Dis (144):38–46, 1981.
Peterson DE, Overholser CD, Williams LT: Endodontic therapy in patients receiving myelosuppressive chemotherapy. Proc J Dent Res (61):276, 1982.
Rakocz M, Serota FT, Nelson LP, Reich DR, Werther PL, August CS: Dental management of the child undergoing bone marrow transplantation, JADA (104):485–488, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Martinus Nijhoff Publishing, The Hague/Boston/London
About this chapter
Cite this chapter
Schubert, M.M., Sullivan, K.M., Izutsu, K.T., Truelove, E.L. (1983). Oral Complications of Bone-Marrow Transplantation. In: Peterson, D.E., Sonis, S.T. (eds) Oral Complications of Cancer Chemotherapy. Developments in Oncology, vol 12. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3912-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3912-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3914-4
Online ISBN: 978-1-4613-3912-0
eBook Packages: Springer Book Archive